Longevity-Derived Financial Instruments as Practical Implementation of Longevity Biomarkers

Time: 10:00 am
day: Day Two


  • Explaining that biomarkers of human longevity possess valuable and precise information about the life expectancy of a given person or cohort. This implies that biomarkers-based methods have a significant impact on longevity risks mitigation
  • Discussing the variety of financial instruments that are highly exposed to longevity risks:

– Equity reverse mortgage, allowing enhanced longevity risks optimization for both the customer and the provider

– Loan management for retirees

– In longevity annuity contracts-providing feasible means for risk hedging

– Longevity-tied derivatives can benefit from the implementation of the biomarkers-based longevity indices